The Scientist

» colon cancer

Most Recent

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

1 Comment

image: Managing Methylation

Managing Methylation

By | January 1, 2016

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Organoid Biobank

Organoid Biobank

By | May 11, 2015

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: High-Tech Yogurt Could Detect Disease

High-Tech Yogurt Could Detect Disease

By | October 16, 2014

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

2 Comments

image: Obesity Complicates Colorectal Cancer

Obesity Complicates Colorectal Cancer

By | April 9, 2014

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

1 Comment

image: Bacteria’s Role in Bowel Cancer

Bacteria’s Role in Bowel Cancer

By | March 3, 2014

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

3 Comments

image: Next Generation: Cancer Drug in Disguise

Next Generation: Cancer Drug in Disguise

By | November 5, 2013

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

2 Comments

image: Fewer Mutations in Tumor Mitochondria

Fewer Mutations in Tumor Mitochondria

By | June 7, 2012

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

1 Comment

image: Helpful Bacterial Metabolites

Helpful Bacterial Metabolites

By | August 1, 2011

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

3 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech